Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These ap...
Cote: | Libro Electrónico |
---|---|
Auteur principal: | |
Collectivité auteur: | |
Format: | Électronique eBook |
Langue: | Inglés |
Publié: |
New York, NY :
Springer New York : Imprint: Springer,
2012.
|
Édition: | 1st ed. 2012. |
Collection: | SpringerBriefs in Pharmaceutical Science & Drug Development,
|
Sujets: | |
Accès en ligne: | Texto Completo |